Veterinary Autoimmune Disease Therapeutics Global Market Report 2025
상품코드:1793441
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
수의학 자가면역 질환 치료제 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.2%를 나타내 43억 9,000만 달러로 성장할 전망입니다. 예측기간의 성장은 생명공학의 발전, 동물보건에 대한 투자 증가, 반려동물의 자가면역 질환 유병률 증가, 신규 치료제 개발, 반려동물 보험 도입 증가로 인한 것으로 보입니다. 예측 기간의 주요 동향으로는 맞춤형 의료, 생물 제제의 사용, 원격 의료의 통합, 재생 요법의 채용, 홀리스틱 통합 치료의 중시 등이 있습니다..
향후 5년간의 성장률 6.2%라고 하는 예측은 전회의 예측으로부터 0.1%의 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 스위스나 인도 등 주요 공급국에서 생체활성화합물과 정밀약제 투입에 대한 관세가 상승하면 생산비용이 높아지고 자가면역치료제에 대한 접근이 제한될 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.
수의학에서 연구 자금 증가는 앞으로 수년간 수의학 자가면역 질환 치료제 시장 성장을 가속할 것으로 예측됩니다. 동물의 질병, 장애, 상해 예방, 진단, 치료에 중점을 둔 수의학은 인류 공통 감염 증가, 반려동물 산업의 확대, 동물 건강에 관한 기술의 진보, 농업의 요구, 야생 동물의 보호 활동 등 다양한 요인에 의해 더 많은 자금을 받고 있습니다. 이러한 자금 제공 증가는 질병의 메커니즘, 진단 도구 및 치료법에 관한 연구를 포함한 수의학자가 면역 질환에 대한 연구를 지원하는 것으로, 이러한 질병을 효과적으로 진단하고 관리하는 능력을 향상시킵니다. 예를 들어, 국립식량농업연구소는 2024년 8월 미국 전역의 2022 회계 연도에 320만 달러를 농촌의 식용 동물 수의학에 투자하는 '수의학 서비스 보조금 프로그램'을 발표했습니다. 따라서 수의학에서 연구 자금 증가는 수의학 자가면역 질환 치료제 시장 성장을 가속하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 수의학 자가면역 질환 치료제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 수의학 자가면역 질환 치료제 시장 : 성장률 분석
세계의 수의학 자가면역 질환 치료제 시장 실적 : 규모와 성장(2019-2024년)
세계의 수의학 자가면역 질환 치료제 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 수의학 자가면역 질환 치료제 : 전체 시장(TAM)
제6장 시장 세분화
세계의 수의학 자가면역 질환 치료제 시장 : 요법 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
코르티코스테로이드
아자티오프린
사이클로스포린
마이코페놀 레이트
레플루노마이드
사이클로포스파미드
레보티록신
엽산
히드록시클로로퀸
클로로퀸
세계의 수의학 자가면역 질환 치료제 시장 : 동물 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
반려 동물
가축 동물
기타 동물
세계의 수의학 자가면역 질환 치료제 시장 : 질환별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
갑상선 기능 저하증
천포창 질환
개 루프스
자가면역 용혈성 빈혈
수포성 천포창
원판형 홍반성 루푸스(DLE)
면역 관련 관절염
기타 질환
세계의 수의학 자가면역 질환 치료제 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
동물병원
수의사 클리닉
세계의 수의학 자가면역 질환 치료제 시장 : 코르티코스테로이드 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
프레드니손
프레드니솔론
덱사메타손
메틸 프레드니솔론
트리암시놀론
세계의 수의학 자가면역 질환 치료제 시장 : 아자티오프린 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
아자티오프린 경구 제
아자티오프린 주사제 제형
세계의 수의학 자가면역 질환 치료제 시장 : 사이클로스포린 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구용 사이클로스포린(아토피)
주사형 사이클로스포린
세계의 수의학 자가면역 질환 치료제 시장 : 마이코페놀 레이트 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
마이코페놀 레이트 모페틸(경구 형태)
마이코페놀 레이트 나트륨(주사제)
세계의 수의학 자가면역 질환 치료제 시장 : 레플루노마이드 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
레플루노마이드 정제(경구)
레플루노마이드 주사
세계의 수의학 자가면역 질환 치료제 시장 : 사이클로포스파미드 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구용 사이클로포스파미드
주사용 사이클로포스파미드
세계의 수의학 자가면역 질환 치료제 시장 : 레보티록신 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
레보티록신 나트륨 정제(경구)
레보티록신 나트륨 주사
세계의 수의학 자가면역 질환 치료제 시장 : 엽산 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
엽산 보충제(경구)
주사용 엽산
세계의 수의학 자가면역 질환 치료제 시장 : 히드록시클로로퀸 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
히드록시클로로퀸 정제(경구)
히드록시클로로퀸 주사제
세계의 수의학 자가면역 질환 치료제 시장 : 클로로퀸 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
클로로퀸 정제(경구)
클로로퀸 주사제
제7장 지역별/국가별 분석
세계의 수의학 자가면역 질환 치료제 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 수의학 자가면역 질환 치료제 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
수의학 자가면역 질환 치료제 시장 : 경쟁 구도
수의학 자가면역 질환 치료제 시장 : 기업 프로파일
Pfizer Inc : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co Inc : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
GlaxoSmithKline
Takeda Pharmaceutical Company
Amgen Inc.
Teva Pharmaceuticals Industries Ltd.
Zoetis Inc
Boehringer Ingelheim International GmbH
Sumitomo Pharma Co. Ltd.
IDEXX Laboratories Inc.
Cipla Inc.
Mallinckrodt Pharmaceuticals
Virbac SA
Dechra Pharmaceuticals plc
Neogen Corporation
Vetoquinol SA
Norbrook Laboratories Limited
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
수의학 자가면역 질환 치료제 시장(2029년) : 새로운 기회를 제공하는 국가
수의학 자가면역 질환 치료제 시장(2029년) : 새로운 기회를 제공하는 부문
수의학 자가면역 질환 치료제 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Veterinary autoimmune disease therapeutics encompass treatments tailored to manage and alleviate animal autoimmune conditions. These therapies are geared towards modulating or suppressing the immune response to mitigate inflammation, halt further tissue damage, and enhance the overall well-being and quality of life of affected animals. Given the complexity of these conditions, veterinary autoimmune disease therapeutics necessitate a customized approach, taking into account the specific disease, its severity, and the individual needs of the animal.
The primary types of therapy within veterinary autoimmune disease therapeutics include corticosteroids, azathioprine, cyclosporine, mycophenolate, leflunomide, cyclophosphamide, levothyroxine, folic acid, hydroxychloroquine, and chloroquine. Corticosteroids, derived from steroid hormones produced in the adrenal cortex, are commonly utilized in medicine to diminish inflammation and suppress immune activity. They are administered to various animals, including companion and livestock animals, to address conditions such as disease-type hypothyroidism, pemphigus disease, canine lupus, autoimmune hemolytic anemia, bullous pemphigoid, discoid lupus erythematosus (DLE), immune-related arthritis, among others. These therapeutic agents are typically dispensed through veterinary hospitals and clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.
The veterinary autoimmune disease therapeutics research report is one of a series of new reports from The Business Research Company that provides veterinary autoimmune disease therapeutics market statistics, including the veterinary autoimmune disease therapeutics industry's global market size, regional shares, competitors with a veterinary autoimmune disease therapeutics market share, detailed veterinary autoimmune disease therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary autoimmune disease therapeutics industry. This veterinary autoimmune disease therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The veterinary autoimmune disease therapeutics market size has grown strongly in recent years. It will grow from $3.25 billion in 2024 to $3.46 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to advances in immunology, increased pet ownership, improved diagnostic methods, development of new drug classes, and rising awareness of pet health.
The veterinary autoimmune disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to advancements in biotechnology, growing investment in veterinary healthcare, increasing prevalence of autoimmune diseases in pets, development of novel therapeutics, and rising pet insurance adoption. Major trends in the forecast period include personalized medicine, the use of biologics, the integration of telemedicine, adoption of regenerative therapies, and focus on holistic and integrative treatments personalized medicine, use of biologics, integration of telemedicine, adoption of regenerative therapies, and focus on holistic and integrative treatments.
The forecast of 6.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Rising tariffs on bioactive compounds and precision drug inputs from major suppliers like Switzerland and India could increase production costs and limit access to advanced autoimmune therapeutics. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increased funding for research in veterinary medicine is anticipated to drive the growth of the veterinary autoimmune disease therapeutics market in the coming years. Veterinary medicine, which focuses on preventing, diagnosing, and treating diseases, disorders, and injuries in animals, is receiving more funding due to various factors such as rising zoonotic diseases, the expanding pet industry, technological advancements in animal health, agricultural needs, and wildlife conservation efforts. This increased funding supports research on veterinary autoimmune diseases, including studies on disease mechanisms, diagnostic tools, and treatment options, thereby enhancing the ability to diagnose and manage these conditions effectively. For example, the National Institute of Food and Agriculture announced the Veterinary Service Grants Program in August 2024, investing $3.2 million in rural food animal veterinary medicine in the fiscal year 2022 across the United States. Hence, the heightened research funding in veterinary medicine is propelling the growth of the veterinary autoimmune disease therapeutics market.
Major companies in the veterinary autoimmune disease therapeutics market are focusing on developing advanced technological solutions, such as RenBiologics, to meet key industry needs. RenBiologics specializes in creating innovative therapies for kidney-related conditions and chronic diseases, with a focus on biologics and regenerative medicine to improve outcomes in areas like renal function and transplant success. For example, in January 2024, Biocytogen, a China-based biotechnology company, launched a new sub-brand, RenBiologics, to focus on the out-licensing of fully human antibodies for therapeutic development. This initiative aims to leverage Biocytogen's extensive library of over 400,000 fully human antibody sequences, created using its proprietary RenMice platform. RenBiologics will support collaborations with pharmaceutical and biotechnology companies for co-development and licensing of these antibodies, advancing the potential for novel antibody-based therapeutics. The launch underscores Biocytogen's commitment to becoming a global leader in antibody discovery and accelerating the development of innovative treatments across multiple therapeutic areas.
In March 2024, AbbVie Inc., a US-based biopharmaceutical company specializing in medicines and solutions for complex health issues, acquired Landos Biopharma for $137.5 million. This acquisition enables AbbVie to expand its portfolio in inflammatory bowel diseases by advancing innovative therapies such as NX-13, addressing significant unmet needs in patient care. Landos Biopharma, also based in the US, focuses on developing autoimmune therapies, with potential applications for treating similar conditions in animals.
North America was the largest region in the veterinary autoimmune disease therapeutics market in 2024. The regions covered in the veterinary autoimmune disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the veterinary autoimmune disease therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The veterinary autoimmune disease therapeutics market consists of revenues earned by entities by providing immunosuppressive medications, biologic therapies, supportive therapies and complementary therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary autoimmune disease therapeutics market also includes sales of prednisone, mycophenolate mofetil, and methotrexate. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Autoimmune Disease Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on veterinary autoimmune disease therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for veterinary autoimmune disease therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary autoimmune disease therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Veterinary Autoimmune Disease Therapeutics Market Trends And Strategies
4. Veterinary Autoimmune Disease Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Veterinary Autoimmune Disease Therapeutics Growth Analysis And Strategic Analysis Framework
5.1. Global Veterinary Autoimmune Disease Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Veterinary Autoimmune Disease Therapeutics Market Growth Rate Analysis
5.4. Global Veterinary Autoimmune Disease Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Veterinary Autoimmune Disease Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Veterinary Autoimmune Disease Therapeutics Total Addressable Market (TAM)
6.1. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Azathioprine
Cyclosporine
Mycophenolate
Leflunomide
Cyclophosphamide
Levothyroxine
Folic Acid
Hydroxychloroquine
Chloroquine
6.2. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Companion Animals
Livestock Animals
Other Animals
6.3. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypothyroidism
Pemphigus Disease
Canine Lupus
Auto-Immune Hemolytic Anemia
Bullous Pemphigoid
Discoid Lupus Erythematosus (DLE)
Immune-Related Arthritis
Other Diseases
6.4. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veterinary Hospitals
Veterinary Clinics
6.5. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prednisone
Prednisolone
Dexamethasone
Methylprednisolone
Triamcinolone
6.6. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Azathioprine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Azathioprine Oral Tablets
Azathioprine Injectable Formulation
6.7. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Cyclosporine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Cyclosporine (Atopica)
Injectable Cyclosporine
6.8. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Mycophenolate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mycophenolate Mofetil (Oral Form)
Mycophenolate Sodium (Injectable Form)
6.9. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Leflunomide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Leflunomide Tablets (Oral)
Leflunomide Injection
6.10. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Cyclophosphamide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Cyclophosphamide
Injectable Cyclophosphamide
6.11. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Levothyroxine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Levothyroxine Sodium Tablets (Oral)
Levothyroxine Sodium Injection
6.12. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Folic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Folic Acid Supplements (Oral)
Injectable Folic Acid
6.13. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Hydroxychloroquine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hydroxychloroquine Tablets (Oral)
Hydroxychloroquine Injectable Formulation
6.14. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Chloroquine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chloroquine Tablets (Oral)
Chloroquine Injectable Formulation
7. Veterinary Autoimmune Disease Therapeutics Market Regional And Country Analysis
7.1. Global Veterinary Autoimmune Disease Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Veterinary Autoimmune Disease Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Veterinary Autoimmune Disease Therapeutics Market
9.1. China Veterinary Autoimmune Disease Therapeutics Market Overview
9.2. China Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Veterinary Autoimmune Disease Therapeutics Market
10.1. India Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Veterinary Autoimmune Disease Therapeutics Market
11.1. Japan Veterinary Autoimmune Disease Therapeutics Market Overview
11.2. Japan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Veterinary Autoimmune Disease Therapeutics Market
12.1. Australia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Veterinary Autoimmune Disease Therapeutics Market
13.1. Indonesia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Veterinary Autoimmune Disease Therapeutics Market
14.1. South Korea Veterinary Autoimmune Disease Therapeutics Market Overview
14.2. South Korea Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Veterinary Autoimmune Disease Therapeutics Market
15.1. Western Europe Veterinary Autoimmune Disease Therapeutics Market Overview
15.2. Western Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Veterinary Autoimmune Disease Therapeutics Market
16.1. UK Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market
21.1. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market Overview
21.2. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Veterinary Autoimmune Disease Therapeutics Market
22.1. Russia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Veterinary Autoimmune Disease Therapeutics Market
23.1. North America Veterinary Autoimmune Disease Therapeutics Market Overview
23.2. North America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Veterinary Autoimmune Disease Therapeutics Market
24.1. USA Veterinary Autoimmune Disease Therapeutics Market Overview
24.2. USA Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Veterinary Autoimmune Disease Therapeutics Market
26.1. South America Veterinary Autoimmune Disease Therapeutics Market Overview
26.2. South America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Veterinary Autoimmune Disease Therapeutics Market
27.1. Brazil Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Veterinary Autoimmune Disease Therapeutics Market
28.1. Middle East Veterinary Autoimmune Disease Therapeutics Market Overview
28.2. Middle East Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Veterinary Autoimmune Disease Therapeutics Market
29.1. Africa Veterinary Autoimmune Disease Therapeutics Market Overview
29.2. Africa Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Veterinary Autoimmune Disease Therapeutics Market Competitive Landscape And Company Profiles
